Dr. Ivor Douglas, MD
Claim this profileDenver Health
Studies Sepsis
Studies Septic Shock
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Ivor Douglas, MD is currently running
Reparixin
for Acute Respiratory Distress Syndrome
Study objectives To characterize the efficacy of reparixin in ameliorating lung injury and systemic inflammation and expediting clinical recovery and liberation from mechanical ventilation in adult patients with moderate to severe ARDS (PaO2/FIO2 ratio ≤ 200). To evaluate the safety of reparixin vs. placebo in patients enrolled in the study.
Recruiting0 awards Phase 29 criteria
Reparixin
for COVID-19
This trial is testing a medication called reparixin, taken by mouth, to see if it can help adults hospitalized with severe lung infections like pneumonia and COVID-19. The goal is to see if reparixin can reduce inflammation and stop the disease from getting worse. Patients will receive reparixin along with their usual care. Reparixin has been tested in various critical settings and shown potential in improving survival in patients at high risk for in-hospital mortality.
Recruiting1 award Phase 34 criteria
More about Ivor Douglas, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ivor Douglas, MD has experience with
- Reparixin
- Starling SV- Passive Leg Raise
- Microscan Sublingual Microscopy
- Vexus Ultrasound Scoring
- Urine Collection
- Matching Placebo
Breakdown of trials Ivor Douglas, MD has run
Septic Shock
Coronavirus
Pneumonia
Infections
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ivor Douglas, MD specialize in?
Ivor Douglas, MD focuses on Sepsis and Septic Shock. In particular, much of their work with Sepsis has involved treating patients, or patients who are undergoing treatment.
Is Ivor Douglas, MD currently recruiting for clinical trials?
Yes, Ivor Douglas, MD is currently recruiting for 3 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Ivor Douglas, MD has studied deeply?
Yes, Ivor Douglas, MD has studied treatments such as Reparixin, Starling SV- Passive Leg Raise, Microscan Sublingual Microscopy.
What is the best way to schedule an appointment with Ivor Douglas, MD?
Apply for one of the trials that Ivor Douglas, MD is conducting.
What is the office address of Ivor Douglas, MD?
The office of Ivor Douglas, MD is located at: Denver Health, Denver, Colorado 80204 United States. This is the address for their practice at the Denver Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.